SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

IMVIONIX Acquires Commercial Rights to BEOVU from Novartis

Georgia-based ophthalmology biotechnology company IMVIONIX acquired exclusive commercial rights to BEOVU from Novartis.

NVS

Related stories